JAC Advance Access originally published online on October 11, 2005
Journal of Antimicrobial Chemotherapy 2005 56(5):799-802; doi:10.1093/jac/dki384
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorial |
Journal of Antimicrobial Chemotherapy: optional open access and not-for-profit
1 Journal of Antimicrobial Chemotherapy Editorial Office, 11 The Wharf, 16 Bridge Street, Birmingham B1 2JS, UK; 2 Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK
* Corresponding author. Tel: +44-121-633-0415; Fax: +44-121-643-9497; E-mail: jac{at}bsac.org.uk
Abstract
All JAC articles are currently freely accessible 12 months after publication, a form of deferred open access. From 2006, JAC will offer the option of author-pays open access, so that individual articles can be made open access immediately upon publication. In addition, JAC will allow the deposition by authors of post-prints of the accepted version of their article as encouraged by granting bodies such as the US National Institutes of Health (NIH), and others. We are adopting such policies to support our authors who must comply with the requirements of their funding bodies and institutions, however, we do not believe that deposition of the post-print form of the article is the most useful step for the progression of research, as we shall note in this article. These changes will enable JAC to deliver the potential for expanded access to articles at a rate determined by the desire among the author community to do so, but without compromising the long-term viability of JAC and the services we offer.
Keywords: JAC , author-pays models , post-prints , scientific journal publishing